Hanke, N.; Türk, D.; Selzer, D.; Wiebe, S.; Fernandez, É.; Stopfer, P.; Nock, V.; Lehr, T.
A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug–Drug Interaction Studies. Pharmaceutics 2020, 12, 556.
https://doi.org/10.3390/pharmaceutics12060556
AMA Style
Hanke N, Türk D, Selzer D, Wiebe S, Fernandez É, Stopfer P, Nock V, Lehr T.
A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug–Drug Interaction Studies. Pharmaceutics. 2020; 12(6):556.
https://doi.org/10.3390/pharmaceutics12060556
Chicago/Turabian Style
Hanke, Nina, Denise Türk, Dominik Selzer, Sabrina Wiebe, Éric Fernandez, Peter Stopfer, Valerie Nock, and Thorsten Lehr.
2020. "A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug–Drug Interaction Studies" Pharmaceutics 12, no. 6: 556.
https://doi.org/10.3390/pharmaceutics12060556
APA Style
Hanke, N., Türk, D., Selzer, D., Wiebe, S., Fernandez, É., Stopfer, P., Nock, V., & Lehr, T.
(2020). A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug–Drug Interaction Studies. Pharmaceutics, 12(6), 556.
https://doi.org/10.3390/pharmaceutics12060556